SOD2 and asthma: Additionally, epigenetic modifications to the fetal genome during in utero PM exposure can further increase the risk of asthma, such as the antioxidant superoxide dismutase 2 (SOD2) promoter DNA methylation, and TMEM184A which is involved in the inflammatory response (Zhou et al., 2019; Parikh et al., 2022).